News From The Journal Of Clinical Investigation Online Early

Timing is everything when using IL-7 to boost antiviral immunityCD8+ T cells are an important component of antiviral immune responses. Much research effort is being invested in identifying new ways to boost antiviral immune responses in individuals with chronic viral infections (such as those infected with HIV and hepatitis C virus) and to boost the efficacy of vaccines designed to target these viruses.

More: continued here

Filed under: Pain / Anesthetics on February 7th, 2008